Rooper LM, Yamamoto H, Westra W, Ihler S, Lewis JS, Kiss K (International Agency for Research on Cancer 2022) WHO classification of tumours series, vol 9, 5th edn. Lyon, France
Lopez DC, Hoke ATK, Rooper LM, London NR Jr. (2022) Human papillomavirus-related carcinomas of the sinonasal tract. Curr Otorhinolaryngol Rep 10:291–302
Article PubMed PubMed Central Google Scholar
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin 67(2):93–99
Lewis JS Jr., Beadle B, Bishop JA, Chernock RD, Colasacco C, Kalicanin T, Krane JF, Lacchetti C, Moncur JT, Rocco JW et al (2025) Human papillomavirus testing in head and neck carcinomas: guideline update. Arch Pathol Lab Med 149(6):e115–e150
Faquin WC, Lewis JS Jr., Beadle B, Bishop JA, Chernock RD, Krane JF, Moncur JT, Rocco JW, Schwartz MR, Seethala RR (2025) High-risk HPV testing in head and neck carcinoma: key updates from the 2025 College of American Pathologists Guideline. Head Neck Pathol 19(1):115
Article PubMed PubMed Central Google Scholar
Amanian A, Ishii M, Fakhry C, London NR Jr. (2024) Epidemiologic trends in human papillomavirus-associated sinonasal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 150(7):609–618
Article PubMed PubMed Central Google Scholar
Alos L, Moyano S, Nadal A, Alobid I, Blanch JL, Ayala E, Lloveras B, Quint W, Cardesa A, Ordi J (2009) Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer 115(12):2701–2709
Cohen E, Coviello C, Menaker S, Martinez-Duarte E, Gomez C, Lo K, Kerr D, Franzmann E, Leibowitz J, Sargi Z (2020) P16 and human papillomavirus in sinonasal squamous cell carcinoma. Head Neck 42(8):2021–2029
Jiromaru R, Yamamoto H, Yasumatsu R, Hongo T, Nozaki Y, Hashimoto K, Taguchi K, Masuda M, Nakagawa T, Oda Y (2020) HPV-related sinonasal carcinoma: Clinicopathologic features, diagnostic utility of p16 and Rb immunohistochemistry, and EGFR copy number alteration. Am J Surg Pathol 44(3):305–315
Kilic S, Kilic SS, Kim ES, Baredes S, Mahmoud O, Gray ST, Eloy JA (2017) Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol 7(10):980–989
Oliver JR, Lieberman SM, Tam MM, Liu CZ, Li Z, Hu KS, Morris LGT, Givi B (2020) Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma. Cancer 126(7):1413–1423
Oliver JR, Wang NC, Alapati R, Attwood E, Amanian A, Bur AM, Beahm DD (2026) Improved survival of HPV-related sinonasal squamous cell carcinoma with chemoradiation treatment. Head Neck
Ramkumar SP, Simpson MC, Adjei Boakye E, Bukatko AR, Antisdel JL, Massa ST, Osazuwa-Peters N (2023) High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma. Cancer 129(9):1372–1383
Sharma A, Tang AL, Takiar V, Wise-Draper TM, Langevin SM (2021) Human papillomavirus and survival of sinonasal squamous cell carcinoma patients: a systematic review and meta-analysis. Cancers (Basel) 13(15)
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35
Article CAS PubMed PubMed Central Google Scholar
Pinatti LM, Sinha HN, Brummel CV, Goudsmit CM, Geddes TJ, Wilson GD, Akervall JA, Brenner CJ, Walline HM, Carey TE (2021) Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma. Head Neck 43(2):544–557
Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N (2016) Genomic characterization of viral integration sites in HPV-related cancers. Int J Cancer 139(9):2001–2011
Article CAS PubMed PubMed Central Google Scholar
Olthof NC, Huebbers CU, Kolligs J, Henfling M, Ramaekers FC, Cornet I, van Lent-Albrechts JA, Stegmann AP, Silling S, Wieland U et al (2015) Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer 136(5):E207–218
Article CAS PubMed Google Scholar
Reuschenbach M, Huebbers CU, Prigge ES, Bermejo JL, Kalteis MS, Preuss SF, Seuthe IM, Kolligs J, Speel EJ, Olthof N et al (2015) Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers. Cancer 121(12):1966–1976
Article CAS PubMed Google Scholar
Symer DE, Akagi K, Geiger HM, Song Y, Li G, Emde AK, Xiao W, Jiang B, Corvelo A, Toussaint NC et al (2022) Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers. Genome Res 32(1):55–70
Article CAS PubMed Google Scholar
Kim JH, Moon JH, Kim CY, Jeong HN, Lim YC (2025) KUSCC-192: a novel tonsillar squamous cell carcinoma cell line with mixed (episomal and integrated)-typed human papillomavirus from a Korean patient with tonsil cancer. Head Neck
Zamuner FT, Gunti S, Starrett GJ, Faraji F, Toni T, Saraswathula A, Vu K, Gupta A, Zhang Y, Faden DL et al (2025) Molecular patterns and mechanisms of tumorigenesis in HPV-associated and HPV-independent sinonasal squamous cell carcinoma. Nat Commun 16(1):5285
Article CAS PubMed PubMed Central Google Scholar
Costa R, Carneiro BA, Taxter T, Tavora FA, Kalyan A, Pai SA, Chae YK, Giles FJ (2016) FGFR3-TACC3 fusion in solid tumors: mini review. Oncotarget 7(34):55924–55938
Article PubMed PubMed Central Google Scholar
Agaimy A, Antonescu CR, Bell D, Breimer GE, Dermawan JK, Kester LA, Laco J, Rijken JA, Whaley RD, Stoehr R et al (2025) FGFR3::TACC3 fusions in head and neck carcinomas: a study of nine cases highlighting phenotypic heterogeneity, frequent HPV association, and a morphologically distinct subset in favor of a putative entity. Virchows Arch 486(3):499–510
Article CAS PubMed Google Scholar
Taverna C, Pollastri F, Pecci R, Giannoni B, Fattorini C, Santucci M, Mueller SK, Stoehr R, Franchi A, Agaimy A (2021) Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours. Histopathology 79(3):306–314
Bulanova B, Sykorova V, Mastnikova K, Vaclavikova E, Moravcova J, Vlcek P, Lancova L, Lastuvka P, Katra R, Bavor P et al (2023) BRAF fusion genes in a large cohort of thyroid carcinomas. Endocr Abstracts https://www.endocrineabstracts.org/ea/0092/ea0092op-12-05
Hang JF, Chen JY, Kuo PC, Lai HF, Lee TL, Tai SK, Kuo CS, Chen HS, Li WS, Li CF (2023) A shift in molecular drivers of papillary thyroid carcinoma following the 2017 World Health Organization classification: characterization of 554 consecutive tumors with emphasis on BRAF-negative cases. Mod Pathol 36(9):100242
Article CAS PubMed Google Scholar
Kasaian K, Wiseman SM, Walker BA, Schein JE, Zhao Y, Hirst M, Moore RA, Mungall AJ, Marra MA, Jones SJ (2015) The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy. BMC Cancer 15:984
Article PubMed PubMed Central Google Scholar
Ross JS, Wang K, Chmielecki J, Gay L, Johnson A, Chudnovsky J, Yelensky R, Lipson D, Ali SM, Elvin JA et al (2016) The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int J Cancer 138(4):881–890
Article CAS PubMed Google Scholar
Megan A, Girtman CS, Richmond, Paraic A, Kenny (2021) The MKRN1-BRAF exon4-exon9 fusion is a targetable oncogenic driver. https://doi.org/10.1101/2021.07.22.453427
McFarland CD, Mirny LA, Korolev KS (2014) Tug-of-war between driver and passenger mutations in cancer and other adaptive processes. Proc Natl Acad Sci U S A 111(42):15138–15143
Article CAS PubMed PubMed Central Google Scholar
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C et al (2007) Patterns of somatic mutation in human cancer genomes. Nature 446(7132):153–158
Comments (0)